Trinity Biotech Profit Margin 2006-2019 | TRIB

Current and historical gross margin, operating margin and net profit margin for Trinity Biotech (TRIB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Trinity Biotech net profit margin as of March 31, 2019 is -23.81%.
Trinity Biotech Annual Profit Margins
Trinity Biotech Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.041B $0.097B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.840B 28.17
Medtronic (MDT) Ireland $137.817B 19.69
Stryker (SYK) United States $81.180B 28.07
Boston Scientific (BSX) United States $58.714B 28.48
Baxter (BAX) United States $44.403B 26.93
EssilorLuxottica Societe Anonyme (ESLOY) France $30.829B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.130B 18.00
Coloplast (CLPBY) Denmark $26.395B 42.14
Lonza Group Ag (LZAGY) Switzerland $26.038B 0.00
Terumo (TRUMY) Japan $23.788B 27.35
Smith & Nephew SNATS (SNN) United Kingdom $20.267B 0.00
ResMed (RMD) United States $19.315B 36.83
Sunny Optical Technology (SNPTF) China $13.689B 0.00
Bio-Rad Laboratories (BIO) United States $9.759B 52.32
Canopy Growth (CGC) Canada $9.745B 0.00
Insulet (PODD) United States $9.055B 536.57
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Haemonetics (HAE) United States $7.033B 53.07
Hill-Rom Holdings (HRC) United States $7.032B 20.97
Perrigo (PRGO) Ireland $6.283B 11.57
Aurora Cannabis (ACB) Canada $6.094B 59.90
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
GW Pharmaceuticals (GWPH) United Kingdom $4.651B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.710B 61.70
ICU Medical (ICUI) United States $3.430B 22.25
NuVasive (NUVA) United States $3.316B 26.44
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.552B 25.34
Agios Pharmaceuticals (AGIO) United States $2.491B 0.00
National Vision Holdings (EYE) United States $2.177B 46.98
Cardiovascular Systems (CSII) United States $1.682B 0.00
Aphria (APHA) $1.551B 0.00
Phibro Animal Health (PAHC) United States $1.263B 18.92
AtriCure (ATRC) United States $1.060B 0.00
VAREX IMAGING (VREX) United States $1.018B 23.45
NanoString Technologies (NSTG) United States $0.977B 0.00
Omeros (OMER) United States $0.967B 0.00
PetIQ (PETQ) United States $0.908B 21.44
Lantheus Holdings (LNTH) United States $0.897B 23.57
Eagle Pharmaceuticals (EGRX) United States $0.794B 20.23
Cerus (CERS) United States $0.769B 0.00
MacroGenics (MGNX) United States $0.737B 0.00
Quanterix (QTRX) United States $0.702B 0.00
TG Therapeutics (TGTX) United States $0.648B 0.00
LeMaitre Vascular (LMAT) United States $0.626B 37.08
Surmodics (SRDX) United States $0.601B 114.26
OraSure Technologies (OSUR) United States $0.446B 20.63
Meridian Bioscience (VIVO) United States $0.432B 13.48
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.423B 0.00
BioLife Solutions (BLFS) United States $0.376B 123.63
United Health Products (UEEC) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.349B 25.56
Zynex (ZYXI) United States $0.345B 36.62
Owens & Minor (OMI) United States $0.306B 9.17
Bovie Medical (APYX) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Chimerix (CMRX) United States $0.153B 0.00
Fonar (FONR) United States $0.152B 8.01
Rockwell Medical (RMTI) United States $0.152B 0.00
Female Health (VERU) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.087B 20.65
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Surface Oncology (SURF) United States $0.055B 0.00
Nephros (NEPH) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Senestech (SNES) United States $0.039B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00